Tamara Lotan

36PUBLICATIONS
157CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsLiquid biopsiesEvolutionary computationPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|May 01, 2026
HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer.

|Apr 29, 2026
Evaluation of Tissue from Patients with Prostate Cancer Identifies B7-H3 as an Androgen-Regulated, Broadly Expressed, Combinatorial Therapeutic Target.

|Mar 23, 2026
Subclonal Complete Loss of CDKN1B as a Common Genomic Alteration in Prostate Cancer: Associations with Race and Prostate Cancer Outcomes.

Karen S Sfanos, Rebecca Morton, Julia N Flores

|Feb 16, 2026
Digital pathology-based artificial intelligence algorithms in prostate cancer: inside the 'black box'.

Claire M de la Calle, Alexander S Baras, Tamara L Lotan

|Dec 15, 2025
Prostate cancer molecular subtypes in systematic versus MRI-targeted biopsy cores at active surveillance: association of PTEN and ERG status with extreme grade reclassification.

Claire M de la Calle, Oluwademilade O Dairo, Zhuo Tony Su

|Dec 12, 2025
The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate.

Rajal B Shah, Murali Varma, Ming Zhou

Pageof 6

Frequent Collaborators

7 joint publications

Angelo M De Marzo

6 joint publications

Emmanuel S Antonarakis

6 joint publications

Karen Sfanos

5 joint publications

Eugene Shenderov